Evidence map›Paper›PMID 24799678›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death.

Dan Weng, Robyn Marty-Roix, Sandhya Ganesan, Megan K Proulx, Gregory I Vladimer, William J Kaiser, Edward S Mocarski, Kimberly Pouliot, Francis Ka-Ming Chan, Michelle A Kelliher and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 185 papers.

0numbers the graph read from it
0cells of the map it votes in
185citing papers in PubMed
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

185 citing papers in PubMed, 297 citations in OpenAlex.

  1. Review
  2. Monogenic disorders of the TNF signalling pathway.Nature reviews. Rheumatology · 2026
    Review
  3. Review
  4. Caspase-8 expression in CD8Science advances · 2025
    Article
  5. Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS.Apoptosis : an international journal on programmed cell death · 2025
    Review
  6. Article
  7. Regulation of inflammatory processes by caspases.Nature reviews. Molecular cell biology · 2025
    Review
  8. Article
  9. Article
  10. Raver1 linksProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Article
  13. TLR priming licenses NAIP inflammasome activation by immunoevasive ligands.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

125 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Dan WengProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine.
Robyn Marty-RoixProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine.
Sandhya GanesanProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine.
Megan K ProulxDepartment of Microbiology and Physiological Systems.
Gregory I VladimerProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine.
William J KaiserDepartment of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322;
Edward S MocarskiDepartment of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322;
Kimberly PouliotProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine.
Francis Ka-Ming ChanDepartment of Cancer Biology, and.
Michelle A KelliherDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA 01605;
Phillip A HarrisPattern Recognition Receptor Discovery Performance Unit, Immuno-inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19426;
John BertinPattern Recognition Receptor Discovery Performance Unit, Immuno-inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19426;
Peter J GoughPattern Recognition Receptor Discovery Performance Unit, Immuno-inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19426;
Dmitry M ShayakhmetovLowance Center for Human Immunology, Departments of Pediatrics and Medicine, Emory University, Atlanta, GA 30322; and.
Jon D GoguenDepartment of Microbiology and Physiological Systems.
Katherine A FitzgeraldProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine,Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Neal SilvermanProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine.
Egil LienProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine,Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway Egil.Lien@umassmed.edu.
Innate Pharma (France) · FREmory University · USGlaxoSmithKline (United States) · USUniversity of Massachusetts Chan Medical School · US

Funding

PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
From Drosophila Immunity to Anti-InflammatoriesR01AI060025 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Neal Silverman · 2004 to 2026
$9.4M
Rip Proteins in Innate Immune SignalingR01AI075118 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KELLIHER, MICHELLE ALICE · 2009 to 2024
$6.7M
Innate immunity to adenovirus vectorsR01AI065429 · NIAID · UNIVERSITY OF WASHINGTON · PI SHAYAKHMETOV, DMITRY · 2005 to 2019
$5.6M
Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
The Role of LPS and Toll-like Receptors in PlagueR01AI057588 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIEN, EGIL · 2004 to 2010
$2.6M
Innate Immunity Training ProgramT32AI095213 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2011 to 2025
$2.5M
Role of PISA; a PYHIN Family Member in Intracellular DNA RecognitionR01AI083713 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., LATZ, EICKE · 2009 to 2013
$2.0M
RIP1 and RIP3 regulation of apoptosis, necrosis, and inflammationDP5OD012198 · OD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KAISER, WILLIAM JOSEPH · 2012 to 2016
$1.9M
Innate activation and death signals in health and diseaseR01AI118853 · NIAID · EMORY UNIVERSITY · PI EDWARD S MOCARSKI, EDWARD S. · 2015 to 2018
$1.7M
Innate Immunity and Herpes Simplex PathogensisR01AI064349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FINBERG, ROBERT WILLIAM · 2005 to 2009
$1.6M
NCRR NIH HHS S10 RR027897NCRR NIH HHS S10RR027897NIAID NIH HHS AI057588NIAID NIH HHS AI060025NIAID NIH HHS AI07538NIAID NIH HHS AI083713NIAID NIH HHS AI095213NIAID NIH HHS AI64349NIAID NIH HHS R01 AI057588NIAID NIH HHS R01 AI060025NIAID NIH HHS R01 AI064349NIAID NIH HHS R01 AI065429NIAID NIH HHS R01 AI075118NIAID NIH HHS R01 AI083713NIAID NIH HHS R01 AI118853NIAID NIH HHS R56 AI060025NIAID NIH HHS T32 AI007349NIAID NIH HHS T32 AI007538NIAID NIH HHS T32 AI095213NIDDK NIH HHS DK32520NIDDK NIH HHS P30 DK032520NIH HHS DP5 OD012198
6 · The paper itself

Abstract

A number of pathogens cause host cell death upon infection, and Yersinia pestis, infamous for its role in large pandemics such as the "Black Death" in medieval Europe, induces considerable cytotoxicity. The rapid killing of macrophages induced by Y. pestis, dependent upon type III secretion system effector Yersinia outer protein J (YopJ), is minimally affected by the absence of caspase-1, caspase-11, Fas ligand, and TNF. Caspase-8 is known to mediate apoptotic death in response to infection with several viruses and to regulate programmed necrosis (necroptosis), but its role in bacterially induced cell death is poorly understood. Here we provide genetic evidence for a receptor-interacting protein (RIP) kinase-caspase-8-dependent macrophage apoptotic death pathway after infection with Y. pestis, influenced by Toll-like receptor 4-TIR-domain-containing adapter-inducing interferon-β (TLR4-TRIF). Interestingly, macrophages lacking either RIP1, or caspase-8 and RIP3, also had reduced infection-induced production of IL-1β, IL-18, TNF, and IL-6; impaired activation of the transcription factor NF-κB; and greatly compromised caspase-1 processing. Cleavage of the proform of caspase-1 is associated with triggering inflammasome activity, which leads to the maturation of IL-1β and IL-18, cytokines important to host responses against Y. pestis and many other infectious agents. Our results identify a RIP1-caspase-8/RIP3-dependent caspase-1 activation pathway after Y. pestis challenge. Mice defective in caspase-8 and RIP3 were also highly susceptible to infection and displayed reduced proinflammatory cytokines and myeloid cell death. We propose that caspase-8 and the RIP kinases are key regulators of macrophage cell death, NF-κB and inflammasome activation, and host resistance after Y. pestis infection.

Indexed as

Cell DeathImmunity, InnateAnimalsApoptosisBacterial ProteinsBone Marrow CellsCaspase 8CytokinesMacrophagesMiceMice, Inbred C57BLMice, KnockoutNF-kappa BReceptor-Interacting Protein Serine-Threonine KinasesYersinia InfectionsYersinia pestisBacterial ProteinsCasp8 protein, mouseCaspase 8CytokinesNF-kappa BReceptor-Interacting Protein Serine-Threonine KinasesRipk1 protein, mouseRipk3 protein, mouseYopP protein, Yersinia

Identifiers

PMID24799678
PMCPMC4034196
OpenAlexW2032897380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.